Pathology Grand Rounds - PD-L1 and Beyond: Predictive Biomarkers and Immunotherapy Targets in Non-Small Cell Lung Carcinoma

At the conclusion of this activity, learners should be able to:

* Understand the basis and clinical relevance of PD-L1 immunohistochemical scoring in non-small cell lung carcinoma

* Become familiar with LAG-3 as a biomarker and immunotherapy target in non-small cell lung carcinoma